Edwards Lifesciences (EW) PT Lowered to $138 at SVB Leerink on Weak Guidance

April 27, 2022 7:11 AM EDT Send to a Friend
SVB Leerink analyst Danielle Antalffy lowered the price target on Edwards Lifesciences (NYSE: EW) to $138.00 (from $145.00) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login